Skip to content

Effect of Recombinant FSH on infertility

The effect of recombinant follicle-stimulating hormone (rFSH) on semen parameters after varicocelectomy in infertile men referring to the Comprehensive Women's Hospital (Mohebe-Yas) since September 2014 to September 2015

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015061522757N1
Enrollment
96
Registered
2015-06-22
Start date
2014-09-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Male Infertility. Male infertility

Interventions

Intervention 1: Injection Follitropin / Rcombinant FSH subcutaneously - 75 units / 0.5 ml in the intervention group. Intervention 2: Injection Normal Saline subcutaneously - 0.5 ml in control group.
Treatment - Drugs
Placebo
Injection Follitropin / Rcombinant FSH subcutaneously - 75 units / 0.5 ml in the intervention group
Injection Normal Saline subcutaneously - 0.5 ml in control group

Sponsors

Tehran university of medical sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: varicocelectomy for unilateral idiopathic varicocele; Age 20 to 40 years; patient consent Exclusion criteria: lack of consent; being allergic to pharmaceutical composition

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Sperm count. Timepoint: After varicocelectomy before treatment and 3 months after treatment. Method of measurement: According semen analusis.;Sperm motility. Timepoint: After varicocelectomy before treatment and 3 months after treatment. Method of measurement: According semen analusis.;Sperm morphology. Timepoint: After varicocelectomy before treatment and 3 months after treatment. Method of measurement: According semen analusis.

Secondary

MeasureTime frame
Complications. Timepoint: During the three-month period of treatment. Method of measurement: According case history.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Atoosa Bagheri Behzad

Tehran university of medical sciences

Atoosa.bagheribehzad@yahoo.com+98 21 4216 0852

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026